Hallux Rigidus: Update on Conservative Management.


Journal

Foot and ankle clinics
ISSN: 1558-1934
Titre abrégé: Foot Ankle Clin
Pays: United States
ID NLM: 9615073

Informations de publication

Date de publication:
Sep 2024
Historique:
medline: 28 7 2024
pubmed: 28 7 2024
entrez: 27 7 2024
Statut: ppublish

Résumé

Hallux rigidus is a degenerative arthritic condition affecting the first metatarsophalangeal joint. Prevalence in patients aged 50 years and above is estimated at 20% to 30%, with a portion being symptomatic. Conservative treatment's efficacy is linked to initial pain levels; though shoe modifications and insoles are commonly recommended, their true effectiveness lacks strong evidence. Injection therapy, including corticosteroids and hyaluronic acid, demonstrates varied outcomes, with about 50% of patients undergoing surgery within 1 to 2 years. The condition's etiology remains elusive, but recent biomechanical hypotheses hold promise.

Identifiants

pubmed: 39068017
pii: S1083-7515(23)00169-9
doi: 10.1016/j.fcl.2023.09.010
pii:
doi:

Substances chimiques

Hyaluronic Acid 9004-61-9

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

405-415

Informations de copyright

Copyright © 2023 Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Disclosure The authors have no commercial or financial conflicts of interest related to this work. All pictures and x-rays are from Dr Hanselman’s records.

Auteurs

Antoine S Acker (AS)

Department of Orthopaedic Surgery, Research Scholar, Duke University, Durham, NC, USA; Centre of Foot and Ankle Surgery, Clinique La Colline, Geneva, Switzerland. Electronic address: antoine.acker@duke.edu.

Kepler Alencar Mendes de Carvalho (KA)

Department of Orthopaedic Surgery, Research Scholar, Duke University, Durham, NC, USA.

Andrew E Hanselman (AE)

Department of Orthopaedic Surgery, Research Scholar, Duke University, Durham, NC, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH